Pages that link to "Q40420056"
Jump to navigation
Jump to search
The following pages link to Small peptide inhibitors of the CXCR4 chemokine receptor (CD184) antagonize the activation, migration, and antiapoptotic responses of CXCL12 in chronic lymphocytic leukemia B cells. (Q40420056):
Displaying 50 items.
- Overexpression of the CXCR5 chemokine receptor, and its ligand, CXCL13 in B-cell chronic lymphocytic leukemia (Q24322068) (← links)
- Neutrophils responsive to endogenous IFN-beta regulate tumor angiogenesis and growth in a mouse tumor model (Q24612339) (← links)
- The pathogenesis of chronic lymphocytic leukemia (Q27025715) (← links)
- Bone marrow stromal cells protect lymphoma B-cells from rituximab-induced apoptosis and targeting integrin α-4-β-1 (VLA-4) with natalizumab can overcome this resistance (Q28243054) (← links)
- Attenuation of CXCR4 responses by CCL18 in acute lymphocytic leukemia B cells (Q28285887) (← links)
- Dasatinib inhibits CXCR4 signaling in chronic lymphocytic leukaemia cells and impairs migration towards CXCL12 (Q28484839) (← links)
- Elucidating a key component of cancer metastasis: CXCL12 (SDF-1α) binding to CXCR4. (Q30577284) (← links)
- AMD3100 plus G-CSF can successfully mobilize CD34+ cells from non-Hodgkin's lymphoma, Hodgkin's disease and multiple myeloma patients previously failing mobilization with chemotherapy and/or cytokine treatment: compassionate use data (Q31135878) (← links)
- Role of chemokine network in the development and progression of ovarian cancer: a potential novel pharmacological target (Q33559560) (← links)
- Targeting the CXCR4 pathway using a novel anti-CXCR4 IgG1 antibody (PF-06747143) in chronic lymphocytic leukemia. (Q33708995) (← links)
- Chronic lymphocytic leukemia cells in a lymph node microenvironment depict molecular signature associated with an aggressive disease (Q33934606) (← links)
- The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces apoptosis, down-regulates the CXCR4 chemokine receptor and impairs migration of chronic lymphocytic leukemia cells (Q33952785) (← links)
- Sca-1+ cardiac stem cells mediate acute cardioprotection via paracrine factor SDF-1 following myocardial ischemia/reperfusion (Q34110874) (← links)
- Influence of bone marrow stromal microenvironment on forodesine-induced responses in CLL primary cells (Q34122323) (← links)
- Impact of bone marrow stromal cells on Bcl-2 family members in chronic lymphocytic leukemia (Q34231324) (← links)
- A designed peptide targeting CXCR4 displays anti-acute myelocytic leukemia activity in vitro and in vivo (Q34334084) (← links)
- Small molecule inhibitors of CXCR4. (Q34574987) (← links)
- Essential role of stromally induced hedgehog signaling in B-cell malignancies (Q34651265) (← links)
- Regulation of Mcl-1 expression in context to bone marrow stromal microenvironment in chronic lymphocytic leukemia (Q35022490) (← links)
- Chaetoglobosin A preferentially induces apoptosis in chronic lymphocytic leukemia cells by targeting the cytoskeleton. (Q35054626) (← links)
- ZAP-70 promotes the infiltration of malignant B-lymphocytes into the bone marrow by enhancing signaling and migration after CXCR4 stimulation (Q35061209) (← links)
- Targeting chemokine receptor CXCR4 for treatment of HIV-1 infection, tumor progression, and metastasis (Q35213463) (← links)
- SDF-1/CXCR4 mediates acute protection of cardiac function through myocardial STAT3 signaling following global ischemia/reperfusion injury (Q35395786) (← links)
- Homing of cancer cells to the bone (Q35603135) (← links)
- Sorafenib-induced apoptosis of chronic lymphocytic leukemia cells is associated with downregulation of RAF and myeloid cell leukemia sequence 1 (Mcl-1). (Q35718966) (← links)
- Dysregulated CXCR4 expression promotes lymphoma cell survival and independently predicts disease progression in germinal center B-cell-like diffuse large B-cell lymphoma (Q35742364) (← links)
- Targeting CXCR4 with cell-penetrating pepducins in lymphoma and lymphocytic leukemia (Q35776992) (← links)
- Co-culture of primary CLL cells with bone marrow mesenchymal cells, CD40 ligand and CpG ODN promotes proliferation of chemoresistant CLL cells phenotypically comparable to those proliferating in vivo (Q35781372) (← links)
- Basal and steroid hormone-regulated expression of CXCR4 in human endometrium and endometriosis (Q35830988) (← links)
- Intraclonal complexity in chronic lymphocytic leukemia: fractions enriched in recently born/divided and older/quiescent cells (Q35876847) (← links)
- CXCR4-SDF-1 interaction potentially mediates trafficking of circulating tumor cells in primary breast cancer (Q35928964) (← links)
- AMD3100 disrupts the cross-talk between chronic lymphocytic leukemia cells and a mesenchymal stromal or nurse-like cell-based microenvironment: pre-clinical evidence for its association with chronic lymphocytic leukemia treatments (Q35944653) (← links)
- RhoH is critical for cell-microenvironment interactions in chronic lymphocytic leukemia in mice and humans (Q36010202) (← links)
- A Selective Novel Peroxisome Proliferator-Activated Receptor (PPAR)-α Antagonist Induces Apoptosis and Inhibits Proliferation of CLL Cells In Vitro and In Vivo (Q36025695) (← links)
- Activation of CD44, a receptor for extracellular matrix components, protects chronic lymphocytic leukemia cells from spontaneous and drug induced apoptosis through MCL-1 (Q36111609) (← links)
- Cell Trafficking in Chronic Lymphocytic Leukemia (Q36115034) (← links)
- Treatment with Ibrutinib Inhibits BTK- and VLA-4-Dependent Adhesion of Chronic Lymphocytic Leukemia Cells In Vivo (Q36172601) (← links)
- Improving chemotherapeutic efficiency in acute myeloid leukemia treatments by chemically synthesized peptide interfering with CXCR4/CXCL12 axis (Q36249853) (← links)
- Chemotherapy induces adaptive drug resistance and metastatic potentials via phenotypic CXCR4-expressing cell state transition in ovarian cancer (Q36280164) (← links)
- Stem-cell ecology and stem cells in motion (Q36528727) (← links)
- Ulocuplumab (BMS-936564 / MDX1338): a fully human anti-CXCR4 antibody induces cell death in chronic lymphocytic leukemia mediated through a reactive oxygen species-dependent pathway (Q36771955) (← links)
- Study of the quantitative, functional, cytogenetic, and immunoregulatory properties of bone marrow mesenchymal stem cells in patients with B-cell chronic lymphocytic leukemia (Q36776849) (← links)
- The CXCR4 chemokine receptor in acute and chronic leukaemia: a marrow homing receptor and potential therapeutic target (Q36800490) (← links)
- Biology of chronic lymphocytic leukemia in different microenvironments: clinical and therapeutic implications (Q36862781) (← links)
- Lymphoma microenvironment: culprit or innocent? (Q36959865) (← links)
- B-cell antigen receptor signaling enhances chronic lymphocytic leukemia cell migration and survival: specific targeting with a novel spleen tyrosine kinase inhibitor, R406. (Q37028635) (← links)
- AT-101 induces apoptosis in CLL B cells and overcomes stromal cell-mediated Mcl-1 induction and drug resistance (Q37039117) (← links)
- Effectiveness of AMD3100 in treatment of leukemia and solid tumors: from original discovery to use in current clinical practice (Q37099769) (← links)
- CXCR4 antagonists: targeting the microenvironment in leukemia and other cancers (Q37318768) (← links)
- CXCR4 and matrix metalloproteinase-1 are elevated in breast carcinoma-associated fibroblasts and in normal mammary fibroblasts exposed to factors secreted by breast cancer cells (Q37344836) (← links)